Literature DB >> 29700802

Acute and chronic effects of metabolic acidosis on renal function and structure.

Gennaro Tammaro1, Miriam Zacchia2, Enrica Zona1, Enza Zacchia1, Giovambattista Capasso1.   

Abstract

BACKGROUND: Emerging evidence suggests that chronic metabolic acidosis (CMA) may have significant implications in terms of worsening renal disease in CKD patients, but the effect of CMA on renal function and structure has not been fully elucidated.
METHOD: We studied the acute and chronic consequences of an acid load (AL) on glomerular filtration rate (GFR) and renal histology in C57BL/6 mice. FITC-inulin clearance was performed at several time points; markers of renal fibrosis were studied at mRNA and protein levels; finally, kidney expression of candidate molecules triggering changes in renal function was studied.
RESULTS: Glomerular hyperfiltration occurred within 1-3 days from AL; after 1 week, the GFR returned to baseline and then declined progressively within 15-21 days. The GFR decline was accompanied by the onset of renal fibrosis, as shown by Masson trichrome staining. Markers of renal fibrosis, namely α-smooth muscle actin and collagen-1, increased after 1 day of acid loading in both mRNA and protein levels and remained higher than baseline for up to 21 days. Well-known mediators of renal fibrosis, including transforming growth factor (TGF)-β and the intrarenal renin-angiotensin system (RAS) axis, were increased even before the decline of the GFR.
CONCLUSION: Acid load caused hyperfiltration acutely and a progressive decline of the GFR chronically; the evidence of renal fibrosis indicates that structural and not only functional renal changes occurred. The concomitant upregulation of TGF-β and intrarenal RAS axis indicates that those factors may be potentially involved in the progression of kidney disease in this setting.

Entities:  

Keywords:  Metabolic acidosis; RAS axis; Renal fibrosis; TGF-β

Mesh:

Substances:

Year:  2018        PMID: 29700802     DOI: 10.1007/s40620-018-0493-3

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  32 in total

1.  The importance of uromodulin as regulator of salt reabsorption along the thick ascending limb.

Authors:  Miriam Zacchia; Giovambattista Capasso
Journal:  Nephrol Dial Transplant       Date:  2014-11-23       Impact factor: 5.992

2.  Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.

Authors:  Claudio Ponticelli; David Cucchiari
Journal:  J Nephrol       Date:  2017-02-17       Impact factor: 3.902

Review 3.  Control of muscle protein kinetics by acid-base balance.

Authors:  Giuseppe Caso; Peter J Garlick
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-01       Impact factor: 4.294

Review 4.  Effect of oral alkali supplementation on progression of chronic kidney disease.

Authors:  Martina Gaggl; Christopher Sliber; Gere Sunder-Plassmann
Journal:  Curr Hypertens Rev       Date:  2014

Review 5.  The role of endothelin in proximal tubule proton secretion and the adaptation to a chronic metabolic acidosis.

Authors:  Kamel Laghmani; Patricia A Preisig; Robert J Alpern
Journal:  J Nephrol       Date:  2002 Mar-Apr       Impact factor: 3.902

6.  The role of the renal ammonia transporter Rhcg in metabolic responses to dietary protein.

Authors:  Lisa Bounoure; Davide Ruffoni; Ralph Müller; Gisela Anna Kuhn; Soline Bourgeois; Olivier Devuyst; Carsten A Wagner
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

Review 7.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

Review 8.  Mechanism of acid-induced bone resorption.

Authors:  Nancy S Krieger; Kevin K Frick; David A Bushinsky
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-07       Impact factor: 2.894

9.  Selective dicer suppression in the kidney alters GSK3β/β-catenin pathways promoting a glomerulocystic disease.

Authors:  Anna Iervolino; Francesco Trepiccione; Federica Petrillo; Manuela Spagnuolo; Marzia Scarfò; Daniela Frezzetti; Gabriella De Vita; Mario De Felice; Giovambattista Capasso
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity.

Authors:  Valentina Capobianco; Marianna Caterino; Laura Iaffaldano; Carmela Nardelli; Angelo Sirico; Luigi Del Vecchio; Pasquale Martinelli; Lucio Pastore; Pietro Pucci; Lucia Sacchetti
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

View more
  2 in total

Review 1.  Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.

Authors:  Marcin Adamczak; Stanisław Surma
Journal:  Kidney Dis (Basel)       Date:  2021-06-04

2.  Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.

Authors:  Biagio R Di Iorio; Antonio Bellasi; Kalani L Raphael; Domenico Santoro; Filippo Aucella; Luciano Garofano; Michele Ceccarelli; Luca Di Lullo; Giovanna Capolongo; Mattia Di Iorio; Pasquale Guastaferro; Giovambattista Capasso
Journal:  J Nephrol       Date:  2019-10-09       Impact factor: 3.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.